LON:EMIS EMIS Group (EMIS) Share Price, News & Analysis → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free EMIS Stock Alerts GBX 1,920 0.00 (0.00%) (As of 10/27/2023) Add Compare Share Share Today's Range 1,920▼ 1,92050-Day Range 1,920▼ 1,92052-Week Range 1,250▼ 1,944Volume433,828 shsAverage Volume675,394 shsMarket Capitalization£1.23 billionP/E Ratio4,085.11Dividend Yield2.19%Price TargetN/A Stock AnalysisStock AnalysisChartDividendHeadlinesInsider TradesStock AnalysisChartDividendHeadlinesInsider Trades Get EMIS Group alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About EMIS Group Stock (LON:EMIS)EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.Read More EMIS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMIS Stock News HeadlinesApril 25, 2024 | msn.comSignature View needs to be demolished, Delhi high court toldApril 16, 2024 | msn.comState House Unit probes Kibuku officials over corruptionApril 26, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. April 16, 2024 | msn.comRBI directs lenders to provide ‘key fact statement’ to borrowers, fresh changes to be implemented from October 1April 15, 2024 | msn.comUnlock Your Fortune: Weekly Horoscope, April 15-21, 2024April 15, 2024 | msn.comNeed medical loan? Ashneer Grover makes waves in fintech arena again with ‘ZeroPe’ appApril 12, 2024 | msn.comTaliban to restore properties of displaced Hindus and Sikhs in AfghanistanApril 10, 2024 | msn.comThree Kibuku District officials remanded over fraudApril 26, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 9, 2024 | msn.comWhy Kenyans do not earn interest on M-Pesa balancesApril 5, 2024 | msn.comRBI Policy: Stability in lending rates bodes well for housing sector, say realtorsApril 5, 2024 | msn.comReserve Bank of India's decision shows resolve to ensure price stability, says expertsApril 5, 2024 | msn.comRBI MPC Meeting: Central Bank Holds Repo Rate At 6.5%; Home, Auto EMIs To Remain UnchangedApril 5, 2024 | msn.comRBI Monetary Policy: Will It Reduce Your Home Loan EMIs?; Check What Experts Has To SayApril 5, 2024 | msn.comSoon, you can apply for EMIs, pay credit card bills and increase limits on RuPay credit cards with UPIApril 5, 2024 | msn.comRBI’s decision to hold repo rates will keep housing boom on course, say real estate expertsApril 1, 2024 | msn.comThe Chess Master Trying to Propel Google’s AI PushApril 1, 2024 | msn.comHyundai Department Store launches platform for K-fashion expansionMarch 28, 2024 | msn.comTimely execution of projects is critical for the growth of India’s real estate sectorMarch 27, 2024 | markets.businessinsider.comB2Trader Brokerage Platform - $5M Investment of B2BrokerMarch 26, 2024 | yahoo.comBattleship's Alternate Ending Would Have Had a Butch Cassidy and the Sundance Kid MomentMarch 21, 2024 | msn.comRetail pools continue to display stable performance across asset classes, says ICRAMarch 19, 2024 | msn.comBank of India cuts home loan ratesMarch 15, 2024 | yahoo.comIn Praise of the Incredible Ensemble Cast of AlienMarch 9, 2024 | msn.comEmpowering Women's Finances: Top 10 Investment Plans to Achieve Financial IndependenceFebruary 27, 2024 | msn.comEnfuce: Finnish fintech secures UK e-money licence and appoints ex-Tide boss as chairFebruary 19, 2024 | msn.comTata Group's Market Valuation Is Now Higher Than Pakistan's GDP! DetailsSee More Headlines Receive EMIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:EMIS CUSIPN/A CIKN/A Webwww.emisgroupplc.com Phone+44-113-3803000FaxN/AEmployees1,560Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.47 Trailing P/E Ratio4,085.11 Forward P/E Ratio27.25 P/E Growth1.37Net Income£30.48 million Net Margins17.23% Pretax MarginN/A Return on Equity23.17% Return on Assets7.99% Debt Debt-to-Equity Ratio2.96 Current Ratio1.07 Quick Ratio1.83 Sales & Book Value Annual Sales£176.86 million Price / Sales6.97 Cash FlowGBX 87.67 per share Price / Cash Flow21.90 Book ValueGBX 210 per share Price / Book9.14Miscellaneous Outstanding Shares64,160,000Free FloatN/AMarket Cap£1.23 billion OptionableNot Optionable Beta-0.13 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Andrew John Thorburn (Age 61)CEO & Executive Director Comp: $1.01MMr. Peter J. Southby (Age 50)CFO & Executive Director Comp: $672kMr. Richard JarvisChief Technology OfficerDr. Shaun O'Hanlon (Age 58)Chief Medical Officer Ms. Suzy FosterChief Executive Officer of EMIS Health & EMIS EnterprisePankaj MistryChief Information Security OfficerChristine BensonCompany SecretaryMore ExecutivesKey CompetitorsCranewareLON:CRWClinigen GroupLON:CLINGenusLON:GNSVectura GroupLON:VECSpire Healthcare GroupLON:SPIView All CompetitorsInsidersPeter SouthbyBought 7 shares on 9/15/2023Total: £13,440.00 ($1,920.00/share)Peter SouthbyBought 11 shares on 7/14/2023Total: £154.00 ($14.00/share)Andy ThorburnSold 8,649 sharesTotal: £11.62 M ($1,344.00/share)Peter SouthbyBought 11 shares on 6/15/2023Total: £14,850.00 ($1,350.00/share)Peter SouthbySold 7,933 sharesTotal: £10.60 M ($1,336.00/share)View All Insider Transactions EMIS Stock Analysis - Frequently Asked Questions How have EMIS shares performed in 2024? EMIS Group's stock was trading at GBX 1,920 at the beginning of 2024. Since then, EMIS stock has increased by 0.0% and is now trading at GBX 1,920. View the best growth stocks for 2024 here. How were EMIS Group's earnings last quarter? EMIS Group plc (LON:EMIS) issued its quarterly earnings results on Wednesday, March, 14th. The company reported $47.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $46.30 by $0.90. The company had revenue of $160.35 million for the quarter. EMIS Group had a net margin of 17.23% and a trailing twelve-month return on equity of 23.17%. How often does EMIS Group pay dividends? What is the dividend yield for EMIS Group? EMIS Group declared a dividend on Thursday, September 7th. Investors of record on Thursday, October 5th will be paid a dividend of GBX 21.30 per share on Monday, October 23rd. This represents a dividend yield of 1.11%. The ex-dividend date of this dividend is Thursday, October 5th. This is an increase from the stock's previous dividend of GBX 21.10. The official announcement can be accessed at this link. Read our dividend analysis for EMIS. Is EMIS Group a good dividend stock? EMIS Group (LON:EMIS) pays an annual dividend of GBX 42 per share and currently has a dividend yield of 2.21%. The dividend payout ratio is 8,936.17%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for EMIS. What other stocks do shareholders of EMIS Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other EMIS Group investors own include RM (RM), Shire (SHP), The Character Group (CCT), Babcock International Group (BAB), Croda International (CRDA), James Halstead (JHD), Micro Focus International (MCRO), Nichols (NICL), Poundland Group (PLND) and Renew (RNWH). How do I buy shares of EMIS Group? Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:EMIS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMIS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.